Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Ionta MT"'
Autor:
De Giorgi, U, Carteni, G, Giannarelli, D, Basso, U, Galli, L, Cortesi, E, Caserta, C, Pignata, S, Sabbatini, R, Bearz, A, Buti, S, Lo Re, G, Berruti, A, Bracarda, S, Cognetti, F, Rastelli, F, Fornarini, G, Porta, C, Turci, D, Sternberg, Cn, Procopio, G, Falcone, A, Roila, F, Cascinu, S, Tirelli, U, Giustini, L, Sobrero, A, Cappuzzo, F, Tortora, G, Tassinari, D, Passalacqua, R, Pazzola, A, Surico, G, Maio, M, Benedetti, G, Barone, C, Adamo, V, Ricevuto, E, De Censi, A, Spada, M, Tonini, G, Pinto, C, Ciuffreda, L, Ruggeri, Em, Bengala, C, Scotti, V, Fagnani, D, Bonetti, A, Mitterer, M, Castiglione, F, Bidoli, P, Ferrau, F, Crino, L, Frassoldati, A, Marchetti, P, Mini, E, Scoppola, A, Verusio, C, Favaretto, A, Di Costanzo, F, Fasola, G, Merlano, M, Artioli, F, Di Leo, A, Romito, S, Maestri, A, Giorgio, Cg, Ionta, Mt, Verderame, F, Zampa, G, Numico, G, Minelli, M, Tagliaferri, P, Foa, P, Palmiotti, G, De Placido, S, Mattioli, R, Iuliano, F, Defraia, E, Siena, S, Clerico, M, Salvagno, L, Ceresoli, Gl, Bernardo, A, Di Lieto, M, Moroni, M, Maisano, M, Scartozzi, M, Scagliotti, G, Soraru, M, Pepe, S, Scaltriti, A, Gebbia, V, Testa, E, Lorusso, V, Bordonaro, R, De Signoribus, G, Tedde, N, Santoro, A, Francini, G, Aondio, G
Objective: To report the safety and efficacy results of patients enrolled in the Italian Nivolumab Renal Cell Cancer Expanded Access Programme. Patients and Methods: Patients with metastatic renal cell cancer (mRCC) previously treated with agents tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc1bee2a040cf0f99f4bf3071f70212
http://hdl.handle.net/2318/1693656
http://hdl.handle.net/2318/1693656
Autor:
Ruzzo, Annamaria, Galli, Fabio, Galli, Francesca, Rulli, E, Bagaloni, Irene, Lonardi, S, Bergamo, F, Ronzoni, M, Ionta, Mt, Massidda, B, Pella, N, Mucciarini, C, Labianca, R, Veltri, E, Sozzi, P, Barni, S, Nicolini, M, Biondi, E, Bramati, A, Turci, D, Buscaglia, M, Magnani, Mauro, Graziano, F.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3656::30b2d28daa3e1e7c25823c8ac2cc5747
https://hdl.handle.net/11576/2668419
https://hdl.handle.net/11576/2668419
Autor:
Generali D, Montemurro F, Bordonaro R, Mafodda A, Romito S, Michelotti A, Piovano P, Ionta MT, Bighin C, Sartori D, Frassoldati A, Cazzaniga ME, Riccardi F, Testore F, Vici P, Barone CA, Schirone A, Piacentini F, Nolè F, Molino A, Latini L, Simoncini EL, Roila F, Cognetti F, Nuzzo F, Foglietta J, Minisini AM, Goffredo F, Portera G, Ascione G, Mariani G, Cazzaniga M, contributor
Publikováno v:
The oncologist. 22(6)
BACKGROUND: The BALLET study was an open-label, multicenter, expanded access study designed to allow treatment with everolimus plus exemestane in postmenopausal women with hormone receptor-positive metastatic breast cancer progressed following prior
Autor:
Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Colombino M, Casula M, Manca A, Tanda F, Budroni M, Palmieri G
Publikováno v:
Annals of oncology (Dordr., Online) (2015). doi:10.1093/annonc/mdv340
info:cnr-pdr/source/autori:Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Colombino M, Casula M, Manca A, Tanda F, Budroni M, Palmieri G/titolo:Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status/doi:10.1093%2Fannonc%2Fmdv340/rivista:Annals of oncology (Dordr., Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Colombino M, Casula M, Manca A, Tanda F, Budroni M, Palmieri G/titolo:Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status/doi:10.1093%2Fannonc%2Fmdv340/rivista:Annals of oncology (Dordr., Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Background: Mutation in KRAS gene has been extensively demonstrated to act as a predictor of response to EGFR-targeted agents in patients with colorectal cancer. Less is known about the significance of KRAS mutation as a prognostic factor of disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::ebdf5473d5f11fd74ccfbaef7595a50f
https://publications.cnr.it/doc/340726
https://publications.cnr.it/doc/340726
Autor:
Casaretti R, Comella P, Carlomagno C, Maiorino L, Greco E, Russo A, Sanna G, Barzelloni ML, Massidda B, Formica V, Serci C, Defraia S, Palmieri G, Ionta MT
Publikováno v:
Annals of oncology (Dordr., Online) (2015). doi:10.1093/annonc/mdv344
info:cnr-pdr/source/autori:Casaretti R, Comella P, Carlomagno C, Maiorino L, Greco E, Russo A, Sanna G, Barzelloni ML, Massidda B, Formica V, Serci C, Defraia S, Palmieri G, Ionta MT/titolo:A Single Arm Clinical Trial to Assess the Efficacy and Safety of Panitumumab (Vectibix) in combination with FOLFOX4 Chemotherapy as 1st line treatment in Subjects with Metastatic Gastric or Gastroesophageal Junction adenocarcinoma (VEGA trial). A multicenter Phase II SICOG trial 0802/doi:10.1093%2Fannonc%2Fmdv344/rivista:Annals of oncology (Dordr., Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Casaretti R, Comella P, Carlomagno C, Maiorino L, Greco E, Russo A, Sanna G, Barzelloni ML, Massidda B, Formica V, Serci C, Defraia S, Palmieri G, Ionta MT/titolo:A Single Arm Clinical Trial to Assess the Efficacy and Safety of Panitumumab (Vectibix) in combination with FOLFOX4 Chemotherapy as 1st line treatment in Subjects with Metastatic Gastric or Gastroesophageal Junction adenocarcinoma (VEGA trial). A multicenter Phase II SICOG trial 0802/doi:10.1093%2Fannonc%2Fmdv344/rivista:Annals of oncology (Dordr., Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Background: EGFR overexpression occurs in 27-55% of gastroesophageal adenocarcinomas, and correlates with poor prognosis. We aimed to assess the efficacy and safety of the anti-EGFR antibody Panitumumab (PANIT) in addition to Oxaliplatin, 5-FU and Le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::6d8a9e3d4ade429d60f7b6d675e4389e
http://www.cnr.it/prodotto/i/340717
http://www.cnr.it/prodotto/i/340717
Autor:
COMELLA P, FRASCI G, AVALLONE A, COSTANZO R, GAMBARDELLA A, BIANCO M, BILANCIA D, BUZZI F, BARTOLUCCI R, CIOFFI R, MESSINA V, CARNICELLI P, DE CATALDIS G, DEL GAIZO F, DEL PRETE S, DI LULLO L, FARRIS A, PUTZU C, FILIPPELLI G, OLIVITO V, DIMA G, GUIDA M, IANNELLI A, CONDEMI G, MANCARELLA S, MAIORINO L, MUSICÒ M, MASSIDDA B, IONTA MT, MEREU E, MASULLO P, MUCI D, PACCAGNELLA A, PANZA N, VAGLICA M, ROSELLI M, MARIOTTI S, MILIA V, NATALE D, GHIANI M, BARBATO E., PALMERI, Sergio
We retrospectively assessed tolerability and efficacy of paclitaxel plus gemcitabine combination in 259 patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) enrolled in three randomized SICOG trials according to their age (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::035c702832d651ceb2136611fc9900d2
http://hdl.handle.net/10447/45275
http://hdl.handle.net/10447/45275
Autor:
Roila, F, Ballatori, E, Fabi, A, Fatigoni, S, Chiara, S, Ionta, Mt, Aieta, M, Clerico, M, Palladino, Ma, Indelli, M, Garrone, O, Bustreo, S, Ruggeri, B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3982::134abebfa5e723c769f5fa4fd614c7ce
http://hdl.handle.net/11391/1525720
http://hdl.handle.net/11391/1525720
Autor:
Palomba G, Colombino M, Olmeo N, Massidda B, Cuccu A, Ionta MT, Contu M, Capelli F, Trova V, Sedda T, Farris A, Tanda F, Budroni M, Sardinian Translational Oncology Group (STOG), Palmieri G, Cossu A
Publikováno v:
Tumori. Supplemento 11(2) (2011).
info:cnr-pdr/source/autori:Palomba G, Colombino M, Olmeo N, Massidda B, Cuccu A, Ionta MT, Contu M, Capelli F, Trova V, Sedda T, Farris A, Tanda F, Budroni M, Sardinian Translational Oncology Group (STOG), Palmieri G, Cossu A/titolo:May genetic background affect the incidence rates of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma? Clues from Sardinian population/doi:/rivista:Tumori. Supplemento/anno:2011/pagina_da:/pagina_a:/intervallo_pagine:/volume:11(2)
info:cnr-pdr/source/autori:Palomba G, Colombino M, Olmeo N, Massidda B, Cuccu A, Ionta MT, Contu M, Capelli F, Trova V, Sedda T, Farris A, Tanda F, Budroni M, Sardinian Translational Oncology Group (STOG), Palmieri G, Cossu A/titolo:May genetic background affect the incidence rates of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma? Clues from Sardinian population/doi:/rivista:Tumori. Supplemento/anno:2011/pagina_da:/pagina_a:/intervallo_pagine:/volume:11(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::d6cdb08fee943f23c05ac25b1fea4ce9
https://publications.cnr.it/doc/215866
https://publications.cnr.it/doc/215866
Autor:
Massidda B, Sini MC, Budroni M, Atzori F, Deidda MC, Pusceddu V, Demurtas P, Piras F, Ionta MT, Palmieri G.
Publikováno v:
(2009).
info:cnr-pdr/source/autori:Massidda B, Sini MC, Budroni M, Atzori F, Deidda MC, Pusceddu V, Demurtas P, Piras F, Ionta MT; Palmieri G./titolo:Molecular alterations as candidate biomarkers for predicting response to therapy and prognosis in stage IIIB breast cancer patients/doi:/rivista:/anno:2009/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Massidda B, Sini MC, Budroni M, Atzori F, Deidda MC, Pusceddu V, Demurtas P, Piras F, Ionta MT; Palmieri G./titolo:Molecular alterations as candidate biomarkers for predicting response to therapy and prognosis in stage IIIB breast cancer patients/doi:/rivista:/anno:2009/pagina_da:/pagina_a:/intervallo_pagine:/volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::ddf5d0d29b9c089d326c6bd4f1d5553e
http://www.cnr.it/prodotto/i/104886
http://www.cnr.it/prodotto/i/104886